Diferencia entre revisiones de «Template:Clinically Utilized Antibiotics»
Sin resumen de edición |
(Fix: Remove duplicate groupstyle parameter in β-lactams Navbox subgroup call) |
||
| (No se muestran 12 ediciones intermedias de otro usuario) | |||
| Línea 24: | Línea 24: | ||
* [[Dicloxacillin]] | * [[Dicloxacillin]] | ||
* [[Oxacillin]] | * [[Oxacillin]] | ||
* [[Nafcillin]] | * [[Nafcillin]] | ||
| Línea 32: | Línea 31: | ||
* [[Ampicillin]] | * [[Ampicillin]] | ||
* [[Amoxicillin/Clavulanate]] | * [[Amoxicillin/Clavulanate]] | ||
* [[Ampicillin/ | * [[Ampicillin/Sulbactam]] | ||
| group4 = Anti-Pseudomonal | | group4 = Anti-Pseudomonal | ||
| list4 = | | list4 = | ||
* [[Piperacillin/Tazobactam]] | |||
* [[Piperacillin/ | * [[Ticarcillin/Clavulanate]] | ||
* [[Ticarcillin/ | |||
}} | }} | ||
| Línea 47: | Línea 44: | ||
* [[Ertapenem]] | * [[Ertapenem]] | ||
* [[Doripenem]] | * [[Doripenem]] | ||
* [[Imipenem]] | * [[Imipenem/Cilastin]] | ||
* [[Meropenem]] | * [[Meropenem]] | ||
| group4= [[Cephalosporins]] | |||
| group4= [[Cephalosporins]] | |||
| list4= {{Navbox subgroup | | list4= {{Navbox subgroup | ||
| groupstyle = background-color: PowderBlue | | groupstyle = background-color: PowderBlue | ||
| Línea 71: | Línea 66: | ||
| group3= 3rd | | group3= 3rd | ||
| list3= | | list3= | ||
* [[Cefdinir]] | *[[Cefdinir]] | ||
* [[Cefotaxime]] | *[[Cefixime]] | ||
* [[Cefpodoxime]] | *[[Cefotaxime]] | ||
* [[Ceftriaxone]] | *[[Cefpodoxime]] | ||
* [[Ceftazidime]] | *[[Ceftriaxone]] | ||
* [[Cefditoren]] | *[[Ceftazidime]] | ||
* [[Ceftibuten]] | *[[Cefditoren]] | ||
*[[Ceftibuten]] | |||
| group4= 4th (antipseudomonal) | | group4= 4th (antipseudomonal) | ||
| Línea 94: | Línea 90: | ||
}} | }} | ||
| group3 = [[Aminoglycosides]] | | group3 = [[Aminoglycosides]] | ||
| Línea 168: | Línea 158: | ||
* [[Ciprofloxacin]] | * [[Ciprofloxacin]] | ||
* [[Ofloxacin]] | * [[Ofloxacin]] | ||
| group3 = 3rd g. | | group3 = 3rd g. | ||
| Línea 190: | Línea 179: | ||
* [[Metronidazole]] | * [[Metronidazole]] | ||
* [[Rifampin]] | * [[Rifampin]] | ||
* [[Vancomycin]] | |||
}}<noinclude> | }}<noinclude> | ||
| Línea 196: | Línea 185: | ||
</noinclude> | </noinclude> | ||
Revisión actual - 14:40 20 mar 2026
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
hlist
How to manage this template's visibility
- Use
{{Clinically Utilized Antibiotics |state=collapsed}}to show this template in its collapsed (hidden) state. - Use
{{Clinically Utilized Antibiotics |state=expanded}}to show this template in its expanded (fully visible) state. - Use
{{Clinically Utilized Antibiotics |state=autocollapse}}to show this template in its collapsed (hidden) state only if there is another template of the same type on the page. - Unless set otherwise (see state parameter within the template's code), autocollapse is the default state.